Celgene target identification and drug discovery capabilities
Celgene has developed target identification and drug discovery technology platforms that enable the company to proceed rapidly from target identification and validation through lead identification and optimisation.
Celgene target and drug discovery process:
On average, it takes over 12 years to develop new medicines.1 Innovative therapies have a limited time in their lifecycle to recapture investment and fund future innovation.
Source: Pharmaceutical Research and Manufacturers of America, Drug Discovery and Development: Understanding the R&D Process. Available at www.innovation.org. Accessed September 2018.
The products represented as in development and found in the product pipeline are intended for investors and members of the media to provide general information on Celgene. This information is not represented to be a complete description and is subject to change without notice. Celgene Corporation may from time to time update this information but does not warrant that will take place at any particular time nor assume any obligation to update this information.
Date of preparation: September 2018